News

ProKidney Set to Present Novel CKD Research at Kidney Week

ProKidney Set to Present Novel CKD Research at Kidney Week

Exciting News from ProKidney Corp.

ProKidney Corp. (NASDAQ: PROK), known for its innovative solutions in chronic kidney disease (CKD), is thrilled to announce that it will present two significant abstracts at the American Society of Nephrology's (ASN) Kidney Week 2025. This annual conference, bringing together experts and researchers in nephrology, offers a platform for the latest advancements in kidney health. ProKidney's participation underlines its commitment to addressing critical aspects of CKD through cellular therapeutics.

Highlights of the Presentation

Among the presentations will be a late-breaking poster detailing the Phase 2 REGEN-007 study results. This study investigates the potential of ProKidney's lead product, rilparencel, in treating diabetes-related kidney damage. The REGEN-007 study shows promise in energizing the conversation around effective treatments for CKD and diabetes, which often go hand-in-hand. ProKidney’s emphasis on cellular therapy is positioned to make a significant impact on patient outcomes.

About the Late-Breaking Presentation

Renal Autologous Cell Therapy in Diabetes and CKD (Phase 2 REGEN-007 Study Results)
Session Title: Late-Breaking Science Posters [LB-PO]
Session Date, Time: November 6, 2025, from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO1203

Exploring Further Research Topics

In addition to the late-breaking poster, ProKidney will also present another impactful poster titled, Cell-Specific Inflammatory Profile Characterization of the Cell Therapy Candidate Rilparencel. This presentation will delve into how understanding inflammatory profiles can enhance the development of individualized therapies for CKD patients, further showcasing ProKidney's commitment to innovative research.

Other Poster Presentation Details

Session Title: Development, Stem Cells, and Regenerative Medicine [PO0600]
Session Date, Time: November 6, 2025, from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO0575

Company Commitment to Knowledge Sharing

Post-event, ProKidney aims to promote transparency and knowledge sharing by making the poster presentations available on its official website. This effort illustrates ProKidney’s dedication not only to innovation in product development but also to disseminating valuable research findings within the medical community.

Availability of Poster Presentations

After the conference, attendees and interested parties can find copies of the presentations on the company's website at https://prokidney.com/our-technology/publications/.

ProKidney's Mission in CKD

Founded in 2015, ProKidney is a frontrunner in CKD treatment through advanced cellular therapies. The company’s flagship product, rilparencel, is designed to provide innovative treatment options for patients facing advanced CKD and type 2 diabetes. ProKidney's research continues to set new standards in regenerative medicine, highlighting the potential for improved patient care.

Stay Updated with ProKidney

To keep pace with advancements in CKD therapies, stakeholders are encouraged to follow ProKidney's developments. The company is active in exploring new treatments aimed at preserving kidney function, which is of critical importance given the increasing prevalence of CKD worldwide.

Contact Information

ProKidney Contact
Ethan Holdaway
Email: Ethan.Holdaway@prokidney.com

Media Contact

Audra Friis
Email: audrafriis@sambrown.com

Investor Relations Contact

Daniel Ferry
Email: Daniel@lifesciadvisors.com

Frequently Asked Questions

What is the main focus of ProKidney Corp.?

ProKidney Corp. focuses on innovative cellular therapeutics for treating chronic kidney disease (CKD).

When will ProKidney present its research?

The presentations at the ASN Kidney Week are scheduled for November 6, 2025.

What are the key topics being presented?

Key topics include the Phase 2 REGEN-007 study results and the inflammatory profile of the therapy candidate rilparencel.

Where can I find more information about the presentations?

Copies of the presentations will be available on ProKidney's website after the event.

How can I contact ProKidney for inquiries?

Contact Ethan Holdaway at Ethan.Holdaway@prokidney.com for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 8

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading

Top 5 Most Recently Viewed Articles

SPS Dominates Outsourcing: 14 Years and Counting

Updated Category News Views 126

SPS just landed on the IAOP Global 100 list yet again—14 years straight. Yeah, that’s a helluva streak in the outsourcing game. But here’s the kicker: while they’re puffing up their feathers about innovation and transformation, traders gotta ask—what's really under the hood? Sure, SPS offers tech-driven solutions aimed at hybrid workplaces and has more than...

Continue Reading
Liberty Service Partners Strengthens Portfolio with Acquisition

Updated Category News Views 420

Liberty Service Partners Acquires Wilson Heating & Air Conditioning Liberty Service Partners is excited to announce its latest partnership with Wilson Heating and Air Conditioning, a recognized leader in residential HVAC services. This acquisition marks a significant step forward for Liberty, showcasing its commitment to expanding its market presence. About Liberty...

Continue Reading
Navient Board Approves Dividend for Shareholders in 2025

Updated Category News Views 281

Navient Announces First Quarter Dividend for 2025 Navient Corporation (NASDAQ: NAVI) has recently made headlines as its board of directors has taken the significant step of approving a dividend for the first quarter of 2025. This move demonstrates the company’s dedication to returning value to its shareholders, offering them $0.16 per share on its common stock. Dividend...

Continue Reading
MoneyHash Secures $5.2 Million Funding to Enhance Payments

Updated Category News Views 195

MoneyHash Raises Significant Pre-A Funding MoneyHash, the pioneering payment orchestration platform making strides across the Middle East and Africa, has successfully raised $5.2 million in a pre-A funding round. This new influx of capital, led by Flourish Ventures—an investor renowned for supporting innovative financial technologies—carries the potential to reshape...

Continue Reading
National CineMedia Achieves New Heights with Stock Market Surge

Updated Category News Views 71

National CineMedia Stock Hits New Heights National CineMedia (NCMI) has recently garnered attention by reaching a remarkable milestone—its stock price has hit a 52-week high, currently trading at $7.01. This impressive growth reflects a strong year-over-year performance, revealing a phenomenal 44.1% increase over the past year. The surge in investor confidence regarding...

Continue Reading